Indiana IN
Eli Lilly clinical trials reducing rate of COVID-19 hospitalizations
Phase two of clinical trials for an antibody treatment at Eli Lilly is reducing the rate at which patients are being hospitalized with coronavirus. Eli Lilly says the antibody is d…
